Identification of the Eph receptor pathway as a novel target for eicosapentaenoic acid (EPA) modification of gene expression in human colon adenocarcinoma cells (HT-29)

Nutrition and Metabolism

Volumn 7, Issue , 2010, Pages

  Doleman, Joanne F ^a   Eady, John J ^a   Elliott, Ruan M ^a   Foxall, Rob J ^a   Seers, John ^a   Johnson, Ian T ^a   Lund, Elizabeth K ^a  

^a NORWICH RESEARCH PARK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; EPHRIN A2; EPHRIN RECEPTOR; EPHRIN RECEPTOR B4; ICOSAPENTAENOIC ACID; POLYUNSATURATED FATTY ACID; VAV PROTEIN;

ARTICLE; CANCER GROWTH; COLON ADENOCARCINOMA; COLORECTAL CANCER; EPICANTHUS; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 77954401010     PISSN: None     EISSN: 17437075     Source Type: Journal    
DOI: 10.1186/1743-7075-7-56     Document Type: Article

References (50)

1. Molecular mechanisms of action and health benefits of polyunsaturated fatty acids. M Rodriguez-Cruz AR Tovar M del Prado N Torres, Rev Invest Clin 2005 57 457 472 16187707
2. Polyunsaturated fatty acid regulation of gene expression. AM Sessler JM Ntambi, J Nutr 1998 128 923 926 9614148
3. Fatty acid oxidation and signaling in apoptosis. DG Tang E La J Kern JP Kehrer, Biol Chem 2002 383 425 442 10.1515/BC.2002.046 12033433
4. Changes of n-3 and n-6 fatty acids in plasma and circulating cells of normal subjects, after prolonged administration of 20:5 (EPA) and 22:6 (DHA) ethyl esters and prolonged washout. F Marangoni MT Angeli S Colli S Eligini E Tremoli CR Sirtori C Galli, Biochim Biophys Acta 1993 1210 55 62 8257719
5. Relationship between plasma fatty acid composition and diet over previous years in the Italian centers of the European Prospective Investigation into Cancer and Nutrition (EPIC). E Fusconi V Pala E Riboli P Vineis C Sacerdote M Del Pezzo M Santucci de Magistris D Palli G Masala S Sieri, et al. Tumori 2003 89 624 635 14870827
6. Changes in phospholipid profiles in response to dietary advice to consume low fat or mediterranean type diet. EK Lund MA Taylor L Rapoport IT Johnson J Wardle, Proceedings Nutrition Sociaty 2002 61
7. Consumption of fish oil leads to prompt incorporation of eicosapentaenoic acid into colonic mucosa of patients prior to surgery for colorectal cancer, but has no detectable effect on epithelial cytokinetics. JM Gee M Watson JA Matthew M Rhodes CJ Speakman WS Stebbings IT Johnson, J Nutr 1999 129 1862 1865 10498759
8. Fish consumption, n-3 fatty acids, and colorectal cancer: a meta-analysis of prospective cohort studies. A Geelen JM Schouten C Kamphuis BE Stam J Burema JM Renkema EJ Bakker P van't Veer E Kampman, Am J Epidemiol 2007 166 1116 1125 10.1093/aje/kwm197 17823383
9. Effects of cellular redox balance on induction of apoptosis by eicosapentaenoic acid in HT29 colorectal adenocarcinoma cells and rat colon in vivo. P Latham EK Lund JC Brown IT Johnson, Gut 2001 49 97 105 10.1136/gut.49.1.97 11413117
10. Dietary n-3 PUFA increases the apoptotic response to 1,2- dimethylhydrazine, reduces mitosis and suppresses the induction of carcinogenesis in the rat colon. P Latham EK Lund IT Johnson, Carcinogenesis 1999 20 645 650 10.1093/carcin/20.4.645 10223194
11. Effect of omega-3 fatty acids on rectal mucosal cell proliferation in subjects at risk for colon cancer. M Anti G Marra F Armelao GM Bartoli R Ficarelli A Percesepe I De Vitis G Maria L Sofo GL Rapaccini, et al. Gastroenterology 1992 103 883 891 1386825
12. Rectal epithelial cell proliferation patterns as predictors of adenomatous colorectal polyp recurrence. M Anti G Marra F Armelao A Percesepe R Ficarelli GM Ricciuto A Valenti GL Rapaccini I De Vitis G D'Agostino, et al. Gut 1993 34 525 530 10.1136/gut.34.4.525 8491402
13. Effect of eicosapentaenoic acid on the proliferation and incidence of apoptosis in the colorectal cell line HT29. RG Clarke EK Lund P Latham AC Pinder IT Johnson, Lipids 1999 34 1287 1295 10.1007/s11745-999-0480-7 10652988
14. Chemopreventive n-3 polyunsaturated fatty acids reprogram genetic signatures during colon cancer initiation and progression in the rat. LA Davidson DV Nguyen RM Hokanson ES Callaway RB Isett ND Turner ER Dougherty N Wang JR Lupton RJ Carroll RS Chapkin, Cancer Res 2004 64 6797 6804 10.1158/0008-5472.CAN-04-1068 15374999
15. Review article: nutrition, obesity and colorectal cancer. IT Johnson EK Lund, Aliment Pharmacol Ther 2007 26 161 181 10.1111/j.1365-2036.2007.03371.x 17593063
16. n-3 polyunsaturated fatty acids and colon cancer prevention. CE Roynette PC Calder YM Dupertuis C Pichard, Clin Nutr 2004 23 139 151 10.1016/j.clnu.2003. 07.005 15030953
17. Mechanisms by which docosahexaenoic acid and related fatty acids reduce colon cancer risk and inflammatory disorders of the intestine. RS Chapkin J Seo DN McMurray JR Lupton, Chem Phys Lipids 2008 153 14 23 10.1016/j.chemphyslip. 2008.02.011 18346463
18. Polyunsaturated fatty acids are FXR ligands and differentially regulate expression of FXR targets. A Zhao J Yu JL Lew L Huang SD Wright J Cui, DNA Cell Biol 2004 23 519 526 10.1089/1044549041562267 15307955
19. Effects of cellular redox balance on induction of apoptosis by eicosapentaenoic acid in HT29 colorectal adenocarcinoma cells and rat colon in vivo. P Latham EK Lund JC Brown IT Johnson, Gut 2001 49 97 105 10.1136/gut.49.1.97 11413117
20. Protocol for reverse transcription and amino-allyl coupling of RNA. J DeRisi M Garber U A, http://cmgm.stanford.edu/pbrown/protocols/ RTaminoAllylCoupling.html
21. Variation in gene expression profiles of peripheral blood mononuclear cells from healthy volunteers. JJ Eady GM Wortley YM Wormstone JC Hughes SB Astley RJ Foxall JF Doleman RM Elliott, Physiol Genomics 2005 22 402 411 10.1152/physiolgenomics.00080.2005 16014386
22. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. A Subramanian P Tamayo VK Mootha S Mukherjee BL Ebert MA Gillette A Paulovich SL Pomeroy TR Golub ES Lander JP Mesirov, Proc Natl Acad Sci USA 2005 102 15545 15550 10.1073/pnas.0506580102 16199517
23. Pathway mapping tools for analysis of high content data. S Ekins Y Nikolsky A Bugrim E Kirillov T Nikolskaya, Methods Mol Biol 2007 356 319 350 16988414
24. Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial. Y Freund-Levi M Eriksdotter-Jonhagen T Cederholm H Basun G Faxen-Irving A Garlind I Vedin B Vessby LO Wahlund J Palmblad, Arch Neurol 2006 63 1402 1408 10.1001/archneur.63. 10.1402 17030655
25. Effects of fatty acids on metabolism and cell growth of human colon cell lines of different transformation state. N Habermann B Christian B Luckas BL Pool-Zobel EK Lund M Glei, Biofactors 2009 35 460 467 10.1002/biof.60 19798733
26. Docosahexaenoic acid is more potent inhibitor of osteoclast differentiation in RAW 264.7 cells than eicosapentaenoic acid. MM Rahman A Bhattacharya G Fernandes, J Cell Physiol 2008 214 201 209 10.1002/jcp.21188 17929247
27. Eph receptors and ephrins. M Nakamoto, Int J Biochem Cell Biol 2000 32 7 12 10.1016/S1357-2725(99)00096-5 10661890
28. Unified nomenclature for Eph family receptors and their ligands, the ephrins. Eph Nomenclature Committee. Cell 1997 90 403 404 10.1016/S0092-8674(00) 80500-0 9267020
29. Over-expression of Eph and ephrin genes in advanced ovarian cancer: ephrin gene expression correlates with shortened survival. NI Herath MD Spanevello S Sabesan T Newton M Cummings S Duffy D Lincoln G Boyle PG Parsons AW Boyd, BMC Cancer 2006 6 144 10.1186/1471-2407-6-144 16737551
30. Receptor protein tyrosine kinase EphB4 is up-regulated in colon cancer. SA Stephenson S Slomka EL Douglas PJ Hewett JE Hardingham, BMC Mol Biol 2001 2 15 10.1186/1471-2199-2-15 11801186
31. The EPH receptor Bs (EPHBs) promoters are unmethylated in colon and ovarian cancers. Q Wu GE Lind HC Aasheim F Micci I Silins CG Trope JM Nesland RA Lothe Z Suo, Epigenetics 2007 2 237 243 10.4161/epi.2.4.5406 18281782
32. The prognostic impact of EphB2/B4 expression on patients with advanced ovarian carcinoma. Q Wu Z Suo GB Kristensen M Baekelandt JM Nesland, Gynecol Oncol 2006 102 15 21 10.1016/j.ygyno.2005.11.034 16499955
33. Expression of Ephb2 and Ephb4 in breast carcinoma. Q Wu Z Suo B Risberg MG Karlsson K Villman JM Nesland, Pathol Oncol Res 2004 10 26 33 10.1007/BF02893405 15029258
34. EphB/EphrinB Receptors and Wnt Signaling in Colorectal Cancer. H Clevers E Batlle, Cancer Res 2006 66 2 5 10.1158/0008-5472.CAN-05-3849 16397205
35. Coexpression of ephrin-Bs and their receptors in colon carcinoma. W Liu SA Ahmad YD Jung N Reinmuth F Fan CD Bucana LM Ellis, Cancer 2002 94 934 939 10.1002/cncr.10122 11920461
36. EphB receptor activity suppresses colorectal cancer progression. E Batlle J Bacani H Begthel S Jonkeer A Gregorieff M van de Born N Malats E Sancho E Boon T Pawson, et al. Nature 2005 435 1126 1130 10.1038/nature03626 15973414
37. Nonsense-mediated decay microarray analysis identifies mutations of EPHB2 in human prostate cancer. P Huusko D Ponciano-Jackson M Wolf JA Kiefer DO Azorsa S Tuzmen D Weaver C Robbins T Moses M Allinen, et al. Nat Genet 2004 36 979 983 10.1038/ng1408 15300251
38. EphB-ephrin-B interactions suppress colorectal cancer progression by compartmentalizing tumor cells. C Cortina S Palomo-Ponce M Iglesias JL Fernandez-Masip A Vivancos G Whissell M Huma N Peiro L Gallego S Jonkheer, et al. Nat Genet 2007 39 1376 1383 10.1038/ng.2007.11 17906625
39. Hox transcription factors and their elusive mammalian gene targets. T Svingen KF Tonissen, Heredity 2006 97 88 96 10.1038/sj.hdy.6800847 16721389
40. Identification of VAV2 on 9q34 and its exclusion as the tuberous sclerosis gene TSC1. EP Henske MP Short S Jozwiak CM Bovey S Ramlakhan JL Haines DJ Kwiatkowski, Ann Hum Genet 1995 59 25 37 10.1111/j.1469-1809.1995.tb01603.x 7762982
41. Vav2 activates Rac1, Cdc42, and RhoA downstream from growth factor receptors but not beta1 integrins. BP Liu K Burridge, Mol Cell Biol 2000 20 7160 7169 10.1128/MCB.20.19.7160-7169.2000 10982832
42. Vav2 is required for cell spreading. PA Marignani CL Carpenter, J Cell Biol 2001 154 177 186 10.1083/jcb.200103134 11448999
43. Altered expression of prolactin receptor-associated signaling proteins in human breast carcinoma. K McHale JE Tomaszewski R Puthiyaveettil VA Livolsi CV Clevenger, Mod Pathol 2008 21 565 571 10.1038/modpathol.2008.7 18246042
44. The Rho family guanine nucleotide exchange factor Vav-2 regulates the development of cell-mediated cytotoxicity. DD Billadeau SM Mackie RA Schoon PJ Leibson, J Exp Med 2000 192 381 392 10.1084/jem.192.3.381 10934226
45. Persistent activation of Rac1 in squamous carcinomas of the head and neck: evidence for an EGFR/Vav2 signaling axis involved in cell invasion. V Patel HM Rosenfeldt R Lyons JM Servitja XR Bustelo M Siroff JS Gutkind, Carcinogenesis 2007 28 1145 1152 10.1093/carcin/bgm008 17234718
46. Polyunsaturated fatty acids including docosahexaenoic and arachidonic acid bind to the retinoid × receptor alpha ligand-binding domain. J Lengqvist A Mata De Urquiza AC Bergman TM Willson J Sjovall T Perlmann WJ Griffiths, Mol Cell Proteomics 2004 3 692 703 10.1074/mcp.M400003-MCP200 15073272
47. Retinal axon growth cones respond to EphB extracellular domains as inhibitory axon guidance cues. E Birgbauer SF Oster CG Severin DW Sretavan, Development 2001 128 3041 3048 11532925
48. A randomised control trial in schoolchildren showed improvement in cognitive function after consuming a bread spread, containing fish flour from a marine source. A Dalton P Wolmarans RC Witthuhn ME van Stuijvenberg SA Swanevelder CM Smuts, Prostaglandins Leukot Essent Fatty Acids 2009 80 143 149 10.1016/j.plefa.2008.12.006 19201180
49. Fish consumption and cognitive function among older people in the UK: baseline data from the OPAL study. AD Dangour E Allen D Elbourne A Fletcher M Richards R Uauy, J Nutr Health Aging 2009 13 198 202 10.1007/s12603-009-0057-2 19262951
50. Evaluating statistical significance of pathways and network in MetaCore http://portal.genego.com/help/P-value-calculations.pdf